Merit Medical Systems, Inc.

NASDAQ:MMSI

Medical - Instruments & Supplies

Healthcare
$85.93 +1.77%

+$1.16 today

Market cap
$5.15B
Beta
0.53
P/E (TTM)
28.4
EPS (TTM)
$2.34
52W Low $59.74High $96.74

Volume 0.46M

Average 0.79M

MMSI Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Merit Medical Systems, Inc.NASDAQ: MMSI

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development dips below year-ago levels

Q3 FY2026 research & development of $22.39M fell 6.6% year over year, behind the +1.0% change in trailing-twelve-month research & development. Sequentially, it fell 11.8% from the prior quarter. Over 3 fiscal years it compounded at +8.8% a year.

Context

  • Research & development amounted to 6.4% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -6.6% toward the trailing-twelve-month pace of +1.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$22.39M-11.8% QoQ
Last fiscal yearDec 2025
$97.35M+16.2% YoY
LTMSep 2026
$96.93M+1.0% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.6%——
1 year+16.2%——
3-year CAGR+8.8%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
97.35M USD
Year-over-year change
+16.2%
4-year CAGR
+8.1%

Research & Development vs competitors

How MMSI compares with its peers on the latest reported figures

  • MMSI's LTM Sep 2026 research & development of $96.93M is the 5th highest of the 10 companies compared; the peer median is $96.27M.
  • Its year-over-year change of +1.0% is the 5th highest of 10, against a peer median of -2.5%.
  • Research & development amounts to 6.0% of revenue for MMSI, versus a peer median of 7.5%.
MMSI Competitors Peer median
Research & Development for MMSI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BSXBoston Scientific CorporationLTM Jun 2026$2.15B +17.3%+15.8%10.3%
BDXBecton, Dickinson and CompanyLTM Sep 2026$1.07B -15.3%-7.2%5.3%
SOLVSolventum CorporationLTM Jun 2026$726M -5.7%-1.2%8.7%
TFXTeleflex IncorporatedLTM Jun 2026$195.47M +23.6%-2.0%7.5%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$96.93M +1.0%+8.8%6.0%
ATRCAtriCure, Inc.LTM Jun 2026$96.27M -10.6%+16.3%16.9%
ICUIICU Medical, Inc.LTM Jun 2026$86.32M -2.5%-2.0%4.0%
CNMDCONMED CorporationLTM Mar 2026$59.27M +10.2%+5.8%4.3%
ANGOAngioDynamics, Inc.LTM Feb 2026$27.86M +5.7%-5.2%8.9%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$14.1M -9.9%+2.1%5.5%
Peer median (excluding MMSI) $96.27M-2.5%-1.2%7.5%

Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.07B1.15B1.26B1.36B1.51B
Cost of Revenue589.42M631.88M673.49M713.18M777.79M
Gross Profit485.33M519.1M583.87M643.33M736.94M
Gross Margin45.2%45.1%46.4%47.4%48.7%
Research & Development71.25M75.51M82.73M83.81M97.35M
Selling, General & Admin335.69M342.53M373.68M376.73M455.21M
Operating Expenses424.42M431.54M458.73M487.64M552.57M
Depreciation & Amortization95.78M92.2M101.29M114.73M134.65M
EBITDA154.96M181.17M228.89M273.97M332.05M
EBITDA Margin14.4%15.7%18.2%20.2%21.9%
Operating Income60.92M87.56M123.94M155.69M184.38M
Operating Margin5.7%7.6%9.9%11.5%12.2%
Interest Income769K439K2.46M26.23M15.07M
Interest Expense5.26M6.34M15.51M31.22M26.46M
Other Income / Expenses(7M)(4.93M)(11.86M)(5.7M)(13.44M)
Income Before Tax53.92M82.63M112.09M149.99M170.94M
Pre-Tax Margin5.0%7.2%8.9%11.1%11.3%
Income Tax Expense5.46M8.11M17.68M29.64M42.45M
Net Income48.45M74.52M94.41M120.36M128.49M
Net Margin4.5%6.5%7.5%8.9%8.5%
EPS (Basic)0.861.311.642.072.17
EPS (Diluted)0.841.291.622.032.13
Weighted Avg Shares56.15M56.81M57.59M58.22M59.16M
Weighted Avg Shares (Diluted)57.36M57.67M58.36M59.37M60.46M

Merit Medical Systems, Inc.

NASDAQ:MMSI

Intrinsic Alpha fair value

Locked

Current Price

$85.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.